UBS Group’s Arvinas ARVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.7M | Buy |
444,674
+376,428
| +552% | +$3.51M | ﹤0.01% | 4477 |
|
|
2026
Q1 | $723K | Sell |
68,246
-98,671
| -59% | -$1.22M | ﹤0.01% | 5802 |
|
|
2025
Q4 | $1.98M | Sell |
166,917
-233,219
| -58% | -$2.55M | ﹤0.01% | 4991 |
|
|
2025
Q3 | $3.41M | Sell |
400,136
-621,517
| -61% | -$4.71M | ﹤0.01% | 4435 |
|
|
2025
Q2 | $7.52M | Buy |
1,021,653
+546,344
| +115% | +$4.02M | ﹤0.01% | 3420 |
|
|
2025
Q1 | $3.34M | Sell |
475,309
-1,563,150
| -77% | -$24.5M | ﹤0.01% | 4212 |
|
|
2024
Q4 | $39.1M | Buy |
2,038,459
+1,566,881
| +332% | +$38.1M | 0.01% | 1678 |
|
|
2024
Q3 | $11.6M | Buy |
471,578
+215,219
| +84% | +$5.62M | ﹤0.01% | 2233 |
|
|
2024
Q2 | $6.82M | Sell |
256,359
-37,685
| -13% | -$1.2M | ﹤0.01% | 2549 |
|
|
2024
Q1 | $12.1M | Buy |
294,044
+37,058
| +14% | +$1.62M | ﹤0.01% | 2109 |
|
|
2023
Q4 | $10.6M | Sell |
256,986
-62,752
| -20% | -$1.47M | ﹤0.01% | 2043 |
|
|
2023
Q3 | $6.28M | Sell |
319,738
-57,778
| -15% | -$1.42M | ﹤0.01% | 2363 |
|
|
2023
Q2 | $9.37M | Sell |
377,516
-22,043
| -6% | -$567K | ﹤0.01% | 2002 |
|
|
2023
Q1 | $10.9M | Buy |
399,559
+71,920
| +22% | +$2.27M | ﹤0.01% | 1827 |
|
|
2022
Q4 | $11.2M | Buy |
327,639
+30,533
| +10% | +$1.28M | ﹤0.01% | 1834 |
|
|
2022
Q3 | $13.2M | Sell |
297,106
-17,191
| -5% | -$835K | 0.01% | 1565 |
|
|
2022
Q2 | $13.2M | Sell |
314,297
-98,730
| -24% | -$4.95M | 0.01% | 1620 |
|
|
2022
Q1 | $27.8M | Buy |
413,027
+126,540
| +44% | +$8.62M | 0.01% | 1201 |
|
|
2021
Q4 | $23.5M | Buy |
286,487
+143,289
| +100% | +$11.7M | 0.01% | 1464 |
|
|
2021
Q3 | $11.8M | Buy |
143,198
+77,270
| +117% | +$6.83M | ﹤0.01% | 1905 |
|
|
2021
Q2 | $5.08M | Buy |
65,928
+64,065
| +3,439% | +$4.45M | ﹤0.01% | 2668 |
|
|
2021
Q1 | $123K | Sell |
1,863
-13,526
| -88% | -$1.03M | ﹤0.01% | 5801 |
|
|
2020
Q4 | $1.31M | Buy |
15,389
+12,964
| +535% | +$447K | ﹤0.01% | 3792 |
|
|
2020
Q3 | $58K | Sell |
2,425
-21,206
| -90% | -$615K | ﹤0.01% | 5533 |
|
|
2020
Q2 | $793K | Buy |
23,631
+9,816
| +71% | +$417K | ﹤0.01% | 3713 |
|
|
2020
Q1 | $557K | Sell |
13,815
-34,651
| -71% | -$1.62M | ﹤0.01% | 3854 |
|
|
2019
Q4 | $1.99M | Sell |
48,466
-14,528
| -23% | -$425K | ﹤0.01% | 3545 |
|
|
2019
Q3 | $1.36M | Buy |
62,994
+28,522
| +83% | +$700K | ﹤0.01% | 3683 |
|
|
2019
Q2 | $758K | Buy |
34,472
+4,130
| +14% | +$86.8K | ﹤0.01% | 3963 |
|
|
2019
Q1 | $447K | Buy |
30,342
+25,994
| +598% | +$461K | ﹤0.01% | 4135 |
|
|
2018
Q4 | $56K | Buy |
+4,348
| New | +$69K | ﹤0.01% | 5985 |
|
Other funds holding ARVN
P
AC
NI
UBS Group's ARVN Position: Q2 2026 in Review
UBS Group increased its Arvinas (ARVN) stake by 552% in Q2 2026, buying an estimated $3.51M and bringing the position to 444,674 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #4477.
UBS Group first reported a position in ARVN in Q4 2018 and has held it in 31 quarters since. The position peaked at $39.1M in Q4 2024. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.
- UBS Group held 444,674 shares of Arvinas worth $3.7M as of Q2 2026.
- UBS Group bought 376,428 Arvinas shares in Q2 2026, an estimated $3.51M.
- Arvinas made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4477 holding.
- UBS Group first reported a position in Arvinas in Q4 2018 and has held it in 31 quarters since.
- UBS Group's Arvinas position peaked at $39.1M in Q4 2024.
- 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.